Table of Contents
Overweight may be caused due to more calorie intake, disorders, hereditary reasons, disease and also environment in some cases. Generally people with a BMI of 40 and above are considered as obese.
Weight loss surgery or bariatric surgery is the commonly used term for various procedures used in treatment of obese. Diet management and intake of pills and supplements are also used to treat obesity non-invasively. Bariatric surgery market can be segmented based on type of surgery, applications, diseases and also different equipment or devices used for the surgery. The treatment may be invasive and non-invasive performed by varied end users like hospitals, clinics/physicians, management centers.
The Global Bariatric Device market has been analyzed with respect to five parameters: by type, by procedure, by cause, by device and by geography. This segment is further divided into various sub segments and is being forecasted till 2020. Around 95% of the bariatric surgeries use invasive device while remaining 5% use non-invasive devices. The procedures or treatments which make use of bariatric devices are classified into 3 types, i.e., restriction surgery, combined surgery and malabsorptive procedures. Each of these has been analyzed in a detailed manner by geography (North America, Europe, Asia-Pacific, and Rest of the World) to provide in-depth information about the global scenario.
At present, Invasive surgery is opted by many as it helps reduce the postoperative pain, blood loss and also decreases scarring pain. Non-invasive surgery causes less damage to the skin and is performed at minute risks. Currently the demand for non-invasive surgery is low but expected to grow significantly in the near future. Non-invasive market is expected to grow at a CAGR of 17% for the next five years.
Please note: this report requires certain updates. We have all the information available but require 2 business days to complete the process and ensure it is as up-to-date as possible.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...
Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...
This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...